Skip to main content
Atrás
Watch Compare

Medicale Corp.

Calidad de datos: 83%
MCLE
OTC Services Health Services
$0.10
▼ $0.05 (-33.33%)
Cap. Mercado: 592,000.0
Precio
$0.10
Cap. Mercado
592,000.0
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -19,748.0

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-2.66

Valoración

PE (TTM)
-17.53
Below sector avg (-1.21)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Services (506 pares)
Métrica Acción Mediana del Sector
P/E -17.5 -1.2
P/B — 1.4
ROE % — -15.8
Net Margin % — -18.3
Rev Growth 5Y % — 4.0
D/E — 0.4

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

No hay estimaciones futuras disponibles

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -33,763.0
ROE N/A ROA N/A
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -19,748.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage -2.66 Asset Turnover N/A
Working Capital -32,202 Tangible Book Value -145,376
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -17.53 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.34%
Market Cap 592,000.0 Enterprise Value 592,000.0
Per Share
EPS (Diluted TTM) -0.01 Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58.49%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0.0 0.0
Net Income -41,153.0 -58,213.0 -37,138.0 -46,419.0 -32,152.0
EPS (Diluted) -0.01 -0.01 -0.01 -0.01 —
Gross Profit — — — — —
Operating Income -33,493.0 -54,707.0 -37,593.0 -46,419.0 -32,152.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 7,501.0 3,506.0 — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 0.0 159.0 159.0 0.0 28,275.0
Total Liabilities 140,086.0 99,092.0 — — —
Shareholders' Equity -140,086.0 -98,933.0 -40,720.0 -54,774.0 -8,355.0
Total Debt — — — — —
Cash & Equivalents — — — — 18,475.0
Current Assets 0.0 159.0 159.0 0.0 18,675.0
Current Liabilities 33,652.0 15,507.0 40,879.0 54,774.0 36,630.0